Physician profile
Jason Cormier
NPI 1982812723
$178,074.65
in general payments reported to CMS, 2019-2025
34 companies · $14K in 2025
The $14K reported for 2025 was more than what 88% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $27K · 2021: $44K · 2022: $52K · 2023: $16K · 2024: $2,314 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $24K · Consulting Fee: $3,200 · Food and Beverage: $2,801 · Travel and Lodging: $2,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $23,945.10 |
| Consulting Fee | $3,200.00 |
| Food and Beverage | $2,800.89 |
| Travel and Lodging | $2,733.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Institute of Musculoskeletal Science and Education | $79,087.63 | 2019-2025 | Enza, Spira |
| Mirus, LLC | $78,686.62 | 2019-2024 | Europa Pedicle Screw System, Cygnus Anterior Cervical Plate |
| Sanara Medtech INC. | $5,414.10 | 2021 | |
| Orthofix Medical, INC. | $3,116.71 | 2019-2023 | Newbridge, M6-C, Forza |
| Alphatec Spine, INC | $2,868.18 | 2019-2020 | |
| Cerapedics INC. | $1,655.00 | 2019 | |
| Stryker Corporation | $1,385.73 | 2019-2021 | |
| Augmedics INC. | $1,097.94 | 2025 | Xvision |
| Camber Spine Technologies LLC | $1,088.22 | 2019-2023 | |
| Aesculap Implant Systems, LLC | $704.50 | 2019 | |
| Centinel Spine, LLC | $632.46 | 2025 | Prodisc C Vivo, Prodisc L, Prodisc C Sk |
| Irras USA, INC. | $270.35 | 2019-2020 | |
| Saluda Medical Americas, INC. | $247.47 | 2023 | Evoke Scs |
| Wenzel Spine, INC. | $246.59 | 2023 | Varilift |
| Nuvasive, INC. | $239.04 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curiteva, INC. | $219.59 | 2022 | |
| Zimmer Biomet Holdings, INC. | $142.35 | 2019 | |
| Ulrich Medical USA, INC. | $123.84 | 2024 | |
| Medtronic, INC. | $121.20 | 2022 | |
| Kuros Biosciences USA, INC | $116.11 | 2022 | |
| Si-Bone, INC. | $111.47 | 2019-2022 | |
| Providence Medical Technology, INC. | $89.34 | 2021 | |
| Depuy Synthes Sales INC. | $87.05 | 2020 | |
| Nevro Corp. | $77.03 | 2020-2022 | |
| Philips North America LLC | $51.72 | 2020 | |
| Aesculap, INC. | $35.90 | 2020 | |
| Arbor Pharmaceuticals, INC. | $34.86 | 2021-2022 | |
| Medtronic USA, INC. | $22.92 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $21.44 | 2019 | |
| Viseon, INC. | $18.35 | 2025 | Maxview System - Lateral Set |
| Ethicon US, LLC | $17.03 | 2025 | Dermabond |
| Misonix INC | $16.78 | 2020 | |
| Boston Scientific Corporation | $15.63 | 2021 | |
| Assertio Therapeutics, INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cormier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.